Atara Biotherapeutics (ATRA) EBT Margin (2021 - 2026)
Atara Biotherapeutics (ATRA) recorded EBT Margin of -767.14% in Q2 2026, down 780.74 percentage points from 13.60% a year earlier but up 36.15 percentage points from the prior quarter.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) EBT Margin (2021 - 2026) Analysis & Trends
On a TTM basis, Atara Biotherapeutics' EBT Margin came in at -268.95% as of Jun 30, 2026, down 272.01 percentage points year-over-year; for FY2025, it was 27.09%, up 93.34 percentage points from FY2024.
- Annual EBT Margin has a four-year change of +1699.14 percentage points (FY2021 to FY2025).
- Across earlier years, EBT Margin came in at -66.24% in FY2024 (+3154.46 pp), -3220.70% in FY2023 (-2861.76 pp), -358.95% in FY2022 (+1313.10 pp) and -1672.05% in FY2021.
- Quarterly EBT Margin has ranged from -30068.55% in Q4 2022 to 38.73% in Q1 2025 over the past five years.
- On a year-over-year basis, EBT Margin has declined for four consecutive quarters, with an average year-over-year change of +370.20 percentage points over the last eight quarters.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 28647.12 percentage points in Q4 2023, against a drop of 28832.21 percentage points in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -803.29% (Q1 2026), -213.54% (Q4 2025) and -123.81% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 41.75% |
| 10 | Atara Biotherapeutics | 127.78 Mn | 117.88 Mn | 439,000.00 | -767.14% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -767.14% |
| Mar 31, 2026 | -803.29% |
| Dec 31, 2025 | -213.54% |
| Sep 30, 2025 | -123.81% |
| Jun 30, 2025 | 13.60% |
| Mar 31, 2025 | 38.73% |
| Dec 31, 2024 | -38.81% |
| Sep 30, 2024 | -54.56% |
| Jun 30, 2024 | -66.51% |
| Mar 31, 2024 | -115.98% |
| Dec 31, 2023 | -1,421.43% |
| Sep 30, 2023 | -3,265.48% |
| Jun 30, 2023 | -7,430.20% |
| Mar 31, 2023 | -6,096.98% |
| Dec 31, 2022 | -30,068.55% |
| Sep 30, 2022 | -1,885.65% |
| Jun 30, 2022 | 35.80% |
| Mar 31, 2022 | -1,204.61% |
| Dec 31, 2021 | -1,236.34% |
| Sep 30, 2021 | -1,576.61% |
API Access
Atara Biotherapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();